# A Rare Presentation of Bilateral Foot Drop in Anti-neutrophil Cytoplasmic Antibody (ANCA)-Negative Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome): A Diagnostic Challenge

**Authors:** Muhammad Mohsin Isar, Mohammed Al-Banna, Mohammad Ghaith Hulo, Reem Abu Salah, Mahmoud Abughazal

PMC · DOI: 10.7759/cureus.86765 · 2025-06-25

## TL;DR

A 65-year-old man with rare bilateral foot drop and high eosinophilia was diagnosed with EGPA, a rare vasculitis, and showed improvement with corticosteroids and cyclophosphamide.

## Contribution

Highlights a rare presentation of EGPA with bilateral foot drop and emphasizes the importance of early diagnosis and treatment.

## Key findings

- The patient showed marked clinical improvement after treatment with corticosteroids and cyclophosphamide.
- EGPA can present with atypical symptoms such as bilateral foot drop and mononeuritis multiplex.
- Early recognition and management are crucial for favorable outcomes in EGPA.

## Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA), known as Churg-Strauss syndrome, is a rare multisystem vasculitis mainly affecting small- to medium-sized vessels. It is characterized by eosinophil-rich granulomatous inflammation and necrotizing vasculitis. EGPA is considered a part of the ANCA-associated vasculitis (AAVs), but it also shares features with hypereosinophilic syndrome (HES), reflecting the dual contributions of vascular inflammation and eosinophilic tissue infiltration to organ damage.

This case report describes a 65-year-old male presenting with progressive bilateral foot drop and marked eosinophilia, ultimately diagnosed with EGPA. His symptoms included sensorimotor deficits and purpuric skin lesions. Investigations revealed mononeuritis multiplex, significant eosinophilia, and pulmonary involvement. The patient was started on high-dose corticosteroids followed by cyclophosphamide, which led to marked clinical improvement.

This case underscores the importance of early recognition and management of EGPA, highlighting its varied clinical manifestations and the potential for favorable outcomes with appropriate management.

## Linked entities

- **Chemicals:** cyclophosphamide (PubChem CID 2907)
- **Diseases:** eosinophilic granulomatosis with polyangiitis (MONDO:0015943), Churg-Strauss syndrome (MONDO:0015943), hypereosinophilic syndrome (MONDO:0015691), ANCA-associated vasculitis (MONDO:0012105)

## Full-text entities

- **Diseases:** sensorimotor deficits (MESH:D020233), purpuric skin lesions (MESH:D012871), EGPA (MESH:D014890), mononeuritis multiplex (MESH:D020422), vasculitis (MESH:D014657), Churg-Strauss Syndrome (MESH:D015267), organ damage (MESH:D000092124), pulmonary involvement (MESH:C566343), Foot Drop (MESH:D020427), eosinophilia (MESH:D004802), HES (MESH:D017681), AAVs (MESH:D056648), inflammation (MESH:D007249)
- **Chemicals:** cyclophosphamide (MESH:D003520)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12296841/full.md

---
Source: https://tomesphere.com/paper/PMC12296841